🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

6 recruiting trials

for Mild Autonomous Cortisol Secretion Adenoma

IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion NCT07361874NA1 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Intervention 1: Adrenalectomy, Intervention 2: Semaglutide New Clinical Decision Support Score Based on Steroid Hormone Profiling in the Diagnosis of MACS NCT07352527n/a1 site📍 Pessac University Hospital, Bordeaux Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS) NCT07104812Phase 21 site📍 Rochester Mayo Clinic · Tests: Osilodrostat 1 MG Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS) NCT07247058Phase 41 site📍 Baltimore Johns Hopkins University · Tests: Osilodrostat (Isturisa) Ultradian Steroid Rhythms in Adrenal Incidentalomas NCT07387419NA1 site📍 Pessac University Hospital, Bordeaux · Tests: U-RYTHM system Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS NCT07138274Phase 21 site📍 Rochester Mayo Clinic · Tests: Metyrapone 250 mg Oral Tablets, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy